Bandingkan Harga & Kinerja Sinar Eka Selaras Tbk. (ERAL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sinar Eka Selaras Tbk. dan Organon Pharma Indonesia Tbk.: Sinar Eka Selaras Tbk. diperdagangkan di Rp320 (kapitalisasi pasar 1,67 T, volume 24 jam 6,96 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sinar Eka Selaras Tbk. jauh lebih besar — sekitar 16× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ERAL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,67 T | 104,4 M |
Volume | 6,96 jt | — |
Lot | 69,56 rb | — |
Perputaran | 2,22 M | — |
Harga Rata-rata | 319,06 | — |
Nilai Transaksi | 2,22 M | — |
Harga Ekuilibrium Indikatif | 320 | — |
Volume Ekuilibrium Indikatif | 1,31 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sinar Eka Selaras Tbk.
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Selengkapnya di halaman ERAL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
